upvote
Issue of pharma development is not that you need a protection from copycats. You need to pass a mountain of regulations and bureaucracy. Most of the medications are easily copyable but would take years to be able to get to the market.

See insulin prices difference in europe vs US

reply
> The question is, how do we prevent China and India from just taking our research and copying it for free

centralize all chemistry research behind the closed doors, weapon-level export controls on U.S.-made fever drugs simply because they are U.S.-made, severely control international collaboration, and so much more.

the problem is that the scientific community will rightfully revolt and the rest of the world will pull ahead of the U.S. in a relatively short amount of time. plus, since open science will have been long dead in the U.S. under such conditions, random breakthroughs at a basement or a non-prestigious university will cease to exist as a concept.

China and India piggybacking is the least bad thing to happen. rather, it's an indicator of how open the open science in the U.S. is

reply
> China and India piggybacking is the least bad thing to happen.

So... the US and European tax- and insurance payers are supposed to pay the billions of dollars for R&D and amortization, just for China to copy everything?

It's bad enough if China does that for their internal market. But they don't stop there, their clones and fakes flood back into our markets as well, leading to regular warnings such as [1] from government authorities for consumer safety.

This is unsustainable on so many levels, it needs to stop.

[1] https://www.swissmedic.ch/swissmedic/de/home/humanarzneimitt...

reply
US and European payers aren't paying for neither R&D nor amortization. They're paying a negotiated price that depends mostly on how much value the drug provides to the patient and the health system. The costs for the producers aren't really a factor.
reply
> It doesn't make sense to extend drug patent lengths though because often enough, after the release of a compound, it takes just a few years for a new and updated version of it to be researched.

I think this is an inversion of cause and effect.

reply